Top compounds associated with response to CT47A2


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.05
mRNA KU-55933 CTRPv2 pan-cancer AAC -0.068 0.05
mRNA austocystin d CTRPv2 pan-cancer AAC -0.07 0.05
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.069 0.05
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.068 0.05
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.068 0.05
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.068 0.05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.06
mRNA indisulam CTRPv2 pan-cancer AAC -0.059 0.06
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.057 0.06
Download CSV